1. World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report, April 2007. 2007, WHO, Geneva, (Accessed 24.04.07)., [
http://www.who.int/hiv/toronto2006/towardsuniversalaccess.pdf
]
2. Cleary S, Boulle A, McIntyre D, Coetzee D: Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township. 2004, Health Systems Trust: Durban, (Accessed March 27, 2006)., [
http://www.hst.org.za/publications/579
]
3. Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ: Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med. 2006, 1: e4-10.1371/journal.pmed.0030004.
4. Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R: When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther. 2006, 11: 63-72.
5. World Health Organization: HIV/AIDS Programme. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for public health approach. 2006 revision. Accessed 15 Jan 2007., [
http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
]